Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Non-cash Items: 2013-2021

Historic Non-cash Items for Arrowhead Pharmaceuticals (ARWR) over the last 9 years, with Sep 2021 value amounting to $2.5 million.

  • Arrowhead Pharmaceuticals' Non-cash Items rose 3330.86% to $83.3 million in Q1 2022 from the same period last year, while for Mar 2022 it was $83.3 million, marking a year-over-year increase of 3330.86%. This contributed to the annual value of $2.5 million for FY2021, which is 14.18% down from last year.
  • According to the latest figures from FY2021, Arrowhead Pharmaceuticals' Non-cash Items is $2.5 million, which was down 14.18% from $2.9 million recorded in FY2020.
  • Arrowhead Pharmaceuticals' 5-year Non-cash Items high stood at $4.0 million for FY2018, and its period low was $2.5 million during FY2021.
  • For the 3-year period, Arrowhead Pharmaceuticals' Non-cash Items averaged around $3.0 million, with its median value being $2.9 million (2020).
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' Non-cash Items plummeted by 73.50% in 2017 and then grew by 17.95% in 2018.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Non-cash Items (Yearly) stood at $3.4 million in 2017, then climbed by 17.95% to $4.0 million in 2018, then declined by 12.08% to $3.5 million in 2019, then fell by 16.80% to $2.9 million in 2020, then dropped by 14.18% to $2.5 million in 2021.